These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20537983)

  • 1. Sox2 is translationally activated by eukaryotic initiation factor 4E in human glioma-initiating cells.
    Ge Y; Zhou F; Chen H; Cui C; Liu D; Li Q; Yang Z; Wu G; Sun S; Gu J; Wei Y; Jiang J
    Biochem Biophys Res Commun; 2010 Jul; 397(4):711-7. PubMed ID: 20537983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
    Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
    Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2.
    Sun H; Zhang S
    Biochem Biophys Res Commun; 2011 Jul; 410(3):692-7. PubMed ID: 21703238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
    Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53.
    Zhu N; Gu L; Findley HW; Zhou M
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1272-9. PubMed ID: 16112647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of cap-dependent mRNA translation increases tumour radiosensitivity through reduction of the hypoxic fraction.
    Rouschop KM; Dubois L; Schaaf MB; van den Beucken T; Lieuwes N; Keulers TG; Savelkouls KG; Bussink J; van der Kogel AJ; Koritzinsky M; Wouters BG
    Radiother Oncol; 2011 Jun; 99(3):385-91. PubMed ID: 21665307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational upregulation of yes accompanies eIF4E-mediated oncogenic transformation.
    Defatta RJ; De Benedetti A
    Int J Oncol; 2003 Dec; 23(6):1709-13. PubMed ID: 14612945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.
    Kjellerup RB; Iversen L; Kragballe K; Johansen C
    Br J Dermatol; 2009 Nov; 161(5):1059-66. PubMed ID: 19663871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of eukaryotic initiation factor-4E (eIF-4E) in regulation of expression of NF-kappaB and its subsequent influence on transcription and activity of heparanase in human colon adenocarcinoma cell line].
    Yang YJ; Zhang YL; Wang JD; Lai ZS; Wang QY; Cui HH
    Ai Zheng; 2003 Oct; 22(10):1023-9. PubMed ID: 14558943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Sox2 in human cervical carcinogenesis.
    Ji J; Zheng PS
    Hum Pathol; 2010 Oct; 41(10):1438-47. PubMed ID: 20709360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta1,4-galactosyltransferase V regulates self-renewal of glioma-initiating cell.
    Wei Y; Zhou F; Ge Y; Chen H; Cui C; Li Q; Liu D; Yang Z; Wu G; Sun S; Gu J; Jiang J
    Biochem Biophys Res Commun; 2010 Jun; 396(3):602-7. PubMed ID: 20417617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E.
    Fierro-Monti I; Mohammed S; Matthiesen R; Santoro R; Burns JS; Williams DJ; Proud CG; Kassem M; Jensen ON; Roepstorff P
    J Proteome Res; 2006 Jun; 5(6):1367-78. PubMed ID: 16739988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation.
    Xing Y; Ge Y; Liu C; Zhang X; Jiang J; Wei Y
    Oncotarget; 2016 Jun; 7(24):36395-36406. PubMed ID: 27119230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX2 expression and amplification in gliomas and glioma cell lines.
    Annovazzi L; Mellai M; Caldera V; Valente G; Schiffer D
    Cancer Genomics Proteomics; 2011; 8(3):139-47. PubMed ID: 21518820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
    Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
    Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z; Mashayekhi F
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
    Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
    Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.